Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Presepsin:Gelsolin Ratio, as a Promising Marker of Sepsis-related Organ Dysfunction: a Pilot Study

NCT05060679 is registered in ClinicalTrials.gov with University of Pecs as lead sponsor.

NCT NCT05060679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Presepsin:Gelsolin Ratio, as a Promising Marker of Sepsis-related Organ Dysfunction: a Pilot Study
Lead sponsor
University of Pecs
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
February 29, 2020
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury due to sepsis, acute respiratory distress syndrome, sepsis, septic shock